Relevant bibliographies by topics / Pancreatic cancer, Radiofrequency ablation, immunity

Academic literature on the topic 'Pancreatic cancer, Radiofrequency ablation, immunity'

Author: Grafiati
Published: 11 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Pancreatic cancer, Radiofrequency ablation, immunity.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Pancreatic cancer, Radiofrequency ablation, immunity"

1

Jarosova, Jana, Peter Macinga, Lenka Krupickova, Martina Fialova, Alzbeta Hujova, Jan Mares, Ondrej Urban, et al. "Impact of Endoluminal Radiofrequency Ablation on Immunity in Pancreatic Cancer and Cholangiocarcinoma." Biomedicines 10, no. 6 (June 6, 2022): 1331. http://dx.doi.org/10.3390/biomedicines10061331.

Full text
Abstract:
Radiofrequency ablation (RFA) is a mini-invasive loco-regional ablation technique that is increasingly being used as a palliative treatment for pancreatic cancer and cholangiocarcinoma. Ablation-triggered immune system stimulation has been proposed as a mechanism behind the systemic effects of RFA. The aim of our study was to investigate the immune response to endoluminal biliary RFA. Peripheral blood samples were collected from patients with pancreatic cancer and cholangiocarcinoma randomised to receive endoluminal biliary radiofrequency ablation + stent (19 patients) or stent only (21 patients). We observed an early increase in IL-6 levels and a delayed increase in CXCL1, CXCL5, and CXCL11 levels as well as an increase in CD8+ and NK cells. However, these changes were not specific to RFA treatment. Explicitly in response to RFA, we observed a delayed increase in serum CXCL1 levels and an early decrease in the number of anti-inflammatory CD206+ blood monocytes. Our study provides the first evidence of endoluminal biliary RFA-based regulation of the systemic immune response in patients with pancreatic cancer and cholangiocarcinoma. These changes were characterised by a general inflammatory response. RFA-specific activation of the adaptive immune system was not confirmed.
APA, Harvard, Vancouver, ISO, and other styles
2

Giardino, A., R. Girelli, I. Frigerio, P. Regi, F. Scopelliti, O. Perbellini, G. Innamorti, M. Bacchion, P. Pederzoli, and C. Bassi. "Immunity stimulation after radiofrequency ablation of locally advanced pancreatic cancer: Preliminary results." HPB 18 (April 2016): e760. http://dx.doi.org/10.1016/j.hpb.2016.01.265.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hadjicostas, P., N. Malakounides, C. Varianos, E. Kitiris, F. Lerni, and P. Symeonides. "Radiofrequency ablation in pancreatic cancer." HPB 8, no. 1 (February 2006): 61–64. http://dx.doi.org/10.1080/13651820500466673.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Sarno, Alessandro, Alessandro Beleù, Riccardo De Robertis, Gabriele Giannotti, Giorgia Tedesco, Salvatore Paiella, and Mirko D'Onofrio. "Radiofrequency Ablation of Pancreatic Cancer." Digestive Disease Interventions 03, no. 02 (May 10, 2019): 133–37. http://dx.doi.org/10.1055/s-0039-1688437.

Full text
Abstract:
AbstractRadiofrequency ablation (RFA) is emerging as a safe and feasible technique to treat various pancreatic lesions. In particular, pancreatic ductal adenocarcinoma (PDAC) is the most frequent treated lesion. Nowadays, PDAC treatment by means of RFA is limited to locally advanced, non-resectable, but non-metastatic lesions. The aim of this article is to describe the RFA technique, its results and possible complications.
APA, Harvard, Vancouver, ISO, and other styles
5

Hlavsa, J., V. Procházka, Z. Kala, T. Andrašina, B. Hemmelová, T. Pavlík, I. Penka, et al. "Radiofrequency ablation of pancreatic cancer." Pancreatology 12, no. 6 (November 2012): 586. http://dx.doi.org/10.1016/j.pan.2012.11.287.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Chen, Sheng-Yang, and Xiao-Yong Li. "Radiofrequency ablation for unresectable pancreatic cancer." World Chinese Journal of Digestology 21, no. 31 (2013): 3383. http://dx.doi.org/10.11569/wcjd.v21.i31.3383.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Logue, Jennifer, Edward Leen, Susan J. Moug, Ross Carter, and Colin McKay. "M1550 Radiofrequency Ablation of Locally Advanced Pancreatic Cancer." Gastroenterology 134, no. 4 (April 2008): A—871. http://dx.doi.org/10.1016/s0016-5085(08)64082-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Giardino, A., G. Innamorati, R. Girelli, I. Frigerio, P. Regi, F. Scopelliti, S. Paiella, P. Pederzoli, C. Bassi, and G. Butturini. "Radiofrequency ablation of locally advanced pancreatic cancer: immunostimulation patterns." HPB 21 (2019): S977—S978. http://dx.doi.org/10.1016/j.hpb.2019.10.1287.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Giardino, A., G. Innamorati, R. Girelli, I. Frigerio, P. Regi, F. Scopelliti, S. Paiella, P. Pederzoli, C. Bassi, and G. Butturini. "Radiofrequency ablation of Locally Advanced Pancreatic Cancer: Immunostimulation Patterns." HPB 21 (2019): S766. http://dx.doi.org/10.1016/j.hpb.2019.10.1523.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Zou, Yi-Ping. "Intraoperative radiofrequency ablation combined with125iodine seed implantation for unresectable pancreatic cancer." World Journal of Gastroenterology 16, no. 40 (2010): 5104. http://dx.doi.org/10.3748/wjg.v16.i40.5104.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Pancreatic cancer, Radiofrequency ablation, immunity"

1

Ji, Jiansong. "Radiofrequency and microwave ablation for pancreatic cancer." In Integrative Pancreatic Intervention Therapy, 341–48. Elsevier, 2021. http://dx.doi.org/10.1016/b978-0-12-819402-7.00013-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Pancreatic cancer, Radiofrequency ablation, immunity"

1

"Clinical application of radiofrequency ablation in the treatment of unresectable pancreatic cancer." In The 2nd World Conference on Humanities and Social Sciences. Francis Academic Press, 2018. http://dx.doi.org/10.25236/wchss.2017.02.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Biasutto, D., S. Stigliano, F. Covotta, and FMD Matteo. "ENDOSCOPIC ULTRASOUND-GUIDED RADIOFREQUENCY ABLATION OF PANCREATIC METASTASIS FROM RENAL CELL CANCER: FEASIBILITY AND SAFETY." In ESGE Days. © Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0040-1704984.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hanks, Bradley, Mary Frecker, and Matthew Moyer. "Optimization of a Compliant Endoscopic Radiofrequency Ablation Electrode." In ASME 2017 International Design Engineering Technical Conferences and Computers and Information in Engineering Conference. American Society of Mechanical Engineers, 2017. http://dx.doi.org/10.1115/detc2017-67357.

Full text
Abstract:
Radiofrequency ablation (RFA) is a common cancer treatment modality for patients who are ineligible for open surgery. There is a need for RFA electrodes that generate heating zones that closely match the geometry of typical tumors, especially for endoscopic ultrasound-guided (EUS) RFA. In this paper, the procedure for optimization of an RFA electrode is presented. First, a novel compliant electrode design is proposed. Next, a thermal ablation model is developed to predict the ablation zone surrounding an RFA electrode in biological tissue. Then, a multi-objective genetic algorithm is used to optimize two cases of the electrode geometry to match the region of destructed tissue to a spherical tumor of specified diameter. This optimization procedure is applied to an EUS-RFA ablation of pancreatic tissue. For a target 2.5cm spherical tumor, the optimal design parameters of the compliant electrode design were found. After simulating 40 generations of 50 designs per generation, both cases converged to optimal solutions. The objective functions were useful for simple electrode designs. For more complex electrode designs, the objective functions were unable to direct the design toward a 2.5cm sphere. The results of the optimization demonstrate how computational models combined with optimization can be used for systematic design of ablation electrodes. The optimization procedure may be applied to RFA of various tissue types for systematic design of electrodes that generate spherical ablation zones.
APA, Harvard, Vancouver, ISO, and other styles
4

Hanks, Bradley W., Mary Frecker, and Matthew Moyer. "Design of a Compliant Endoscopic Ultrasound-Guided Radiofrequency Ablation Probe." In ASME 2016 International Design Engineering Technical Conferences and Computers and Information in Engineering Conference. American Society of Mechanical Engineers, 2016. http://dx.doi.org/10.1115/detc2016-59923.

Full text
Abstract:
Pancreatic cancer is one of the most deadly forms of cancer in the United States. Due to its late diagnosis, only 20% of patients diagnosed with the disease are eligible for surgical resection which is considered the preferred method of treatment. Radiofrequency ablation is a common cancer treatment modality for patients ineligible for open surgery. There is a lack of ablation probes which may be used to generate spherical heating zones which closely match the geometry of typical tumors. In particular, there are no endoscopic ablation probes commercially available in the United States. In this paper the design of a compliant endoscopic radiofrequency ablation probe is presented. This probe features an array of compliant tines which deploy through the cancerous tissue to effectively broaden the ablation zone. A thermal ablation model is used to inform the design of the geometry of the probe. In addition, finite element analysis is used to determine the feasibility of the compliant structures. These design tools are used as aids to inform the design and direct modifications toward a feasible probe which generates a spherical ablation zone.
APA, Harvard, Vancouver, ISO, and other styles
5

Tiankanon, Kasenee, Pradermchai Kongkam, Thanawat Luangsukrerk, Virote Sriuranpong, Chonnipa Nantavithya, Trirat Jantarattana, Arlyn Canones, et al. "IDDF2019-ABS-0171 EUS-Guided radiofrequency ablation as adjunctive treatment for unresectable pancreatic cancer versus chemotherapy alone (ERAP)." In International Digestive Disease Forum (IDDF) 2019, Hong Kong, 8–9 June 2019. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2019. http://dx.doi.org/10.1136/gutjnl-2019-iddfabstracts.179.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Tiankanon, K., P. Kongkam, T. Orprayoon, T. Luangsukrerk, DW Seo, V. Sriuranpong, C. Nantavithya, et al. "EUS-GUIDED RADIOFREQUENCY ABLATION PLUS CHEMOTHERAPY VERSUS CHEMOTHERAPY ALONE FOR UNRESECTABLE PANCREATIC CANCER (ERAP): PRELIMINARY RESULTS OF A PROSPECTIVE COMPARATIVE STUDY." In ESGE Days 2019. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1681343.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Pancreatic cancer, Radiofrequency ablation, immunity' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography